127 related articles for article (PubMed ID: 11920805)
21. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
Grossi P; Mohacsi P; Szabolcs Z; Potena L
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
[TBL] [Abstract][Full Text] [Related]
22. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children.
Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M
Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303
[TBL] [Abstract][Full Text] [Related]
23. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
Amir J; Wolf DG; Levy I
Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
[TBL] [Abstract][Full Text] [Related]
24. Ganciclovir therapy in an immunocompetent child with resistant fever and hepatosplenomegaly due to cytomegalovirus infection. Who and when to treat?
Tezer H; Devrim I; Kara A; Cengiz AB; Seçmeer G
Int J Infect Dis; 2008 May; 12(3):340-2. PubMed ID: 18023387
[No Abstract] [Full Text] [Related]
25. Parenteral ganciclovir treatment of acute CMV infection in the immunocompetent host.
Laing RB; Dykhuizen RS; Smith CC; Molyneaux PJ
Infection; 1997; 25(1):44-6. PubMed ID: 9039539
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment with oral valganciclovir of primary CMV enterocolitis in a congenitally infected infant.
Irizarry K; Honigbaum S; Demmler-Harrison G; Rippel S; Wilsey M
Fetal Pediatr Pathol; 2011; 30(6):437-41. PubMed ID: 21905765
[TBL] [Abstract][Full Text] [Related]
27. Early clinical manifestations and laboratory findings before and after treatment of cytomegalovirus infection in kidney transplant patients.
Siddiqui WA; Al Salmi I; Jha A; Pakkyara A; Yasir M; Shaheen FAM
Saudi J Kidney Dis Transpl; 2017; 28(4):774-781. PubMed ID: 28748879
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.
Höcker B; Zencke S; Krupka K; Fichtner A; Pape L; Dello Strologo L; Guzzo I; Topaloglu R; Kranz B; König J; Bald M; Webb NJ; Noyan A; Dursun H; Marks S; Yalcinkaya F; Thiel F; Billing H; Pohl M; Fehrenbach H; Bruckner T; Tönshoff B
Transplantation; 2016 Apr; 100(4):862-70. PubMed ID: 26736017
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation.
Rayes N; Seehofer D; Schmidt CA; Oettle H; Müller AR; Steinmüller T; Settmacher U; Bechstein WO; Neuhaus P
Transplantation; 2001 Sep; 72(5):881-5. PubMed ID: 11571454
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
[TBL] [Abstract][Full Text] [Related]
31. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
[TBL] [Abstract][Full Text] [Related]
32. Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir.
Müller NF; Schampera M; Jahn G; Malek NP; Berg CP; Hamprecht K
BMC Infect Dis; 2016 Jan; 16():19. PubMed ID: 26787617
[TBL] [Abstract][Full Text] [Related]
33. Ganciclovir therapy in two immunocompetent infants with severe acquired CMV pneumonitis.
Suresh N; Thiruvengadam V
Paediatr Int Child Health; 2013 Feb; 33(1):46-8. PubMed ID: 23485496
[TBL] [Abstract][Full Text] [Related]
34. Oral acyclovir in varicella zoster virus infections in children with acute lymphoblastic leukemia.
Jain Y; Lodha R; Tomar S; Arya LS; Kabra SK
Indian Pediatr; 2000 Nov; 37(11):1239-41. PubMed ID: 11086306
[No Abstract] [Full Text] [Related]
35. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
36. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS
Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364
[TBL] [Abstract][Full Text] [Related]
37. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.
Cvetković RS; Wellington K
Drugs; 2005; 65(6):859-78. PubMed ID: 15819597
[TBL] [Abstract][Full Text] [Related]
38. Absence of effect of glutamic acid hydrochloride on the bioavailability of oral ganciclovir in AIDS patients with cytomegalovirus disease.
Gambertoglio J; Kumar P; Dieterich D; Jacobson MA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):394-6. PubMed ID: 9704949
[No Abstract] [Full Text] [Related]
39. A case of CMV endotheliitis treated with intravitreal ganciclovir injection.
Choi WS; Cho JH; Kim HK; Kim HS; Shin YJ
Korean J Ophthalmol; 2013 Apr; 27(2):130-2. PubMed ID: 23543604
[TBL] [Abstract][Full Text] [Related]
40. [Prolonged treatment with valganciclovir in an infant with congenital cytomegalovirus infection].
Baquero-Artigao F; Romero Gómez MP
An Pediatr (Barc); 2009 Jun; 70(6):578-81. PubMed ID: 19423406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
